The MILESTONE Study: Improving Transition From Child to Adult Mental Health Care (MILESTONE)

November 15, 2017 updated by: Swaran Singh, University of Warwick

The Effectiveness of Managed Transition in Improving the Health and Social Outcomes for Young People Transitioning From Child to Adult Mental Health Care: the MILESTONE Study

This study evaluates the longitudinal health and social outcomes of adolescent mental health service users who are at the transition boundary of their child and adolescent mental health service, and whether the implementation of a model of managed transition at the service boundary benefits them, as compared to usual care.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The MILESTONE study focuses on the period when young people attending a children and adolescents mental health service (CAMHS) need to move on, or "transition", to an adult mental health service (AMHS), if they still require care or treatment. We know from other research that this transition is not always properly managed and that improving the transition process can have a positive impact on the health and well-being of young people in this position. We want to evaluate what impact the different transition experiences have on young people's health and well-being, and whether the process of Managed Transition has any benefits as compared to usual care.

The MILESTONE study is run in eight European countries (UK, Ireland, Belgium, Holland, France, Germany, Italy and Croatia). CAMHS in the study regions are selected to provide the young people in their care that are reaching transition age either usual care or a novel service called "Managed Transition", which includes the use of a new decision support tool, the Transition Readiness and Appropriateness Measure (TRAM). This should help with decision making and enable better transitions by identifying cases for whom transition from CAMHS to AMHS is advisable and appropriate, or who can be safely discharged or referred to a community based service. CAMHS are randomly assigned to provide the intervention of Managed Transition or usual care. The health and well-being of the young people attending these services is assessed at the start of the study and then followed-up for 24 months to see whether they transition to AMHS or are discharged or referred to some other service.

Study Type

Interventional

Enrollment (Anticipated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium
        • Katholieke Universiteit Leuven
      • Split, Croatia
        • University Hospital Split
      • Montpellier, France
        • CHRU Montpellier-St Eloi hospital
      • Ulm, Germany
        • University of Ulm
      • Dublin, Ireland
        • University College Dublin
      • Brescia, Italy
        • IRCCS Fatebenefratelli
      • Barendrecht, Netherlands
        • Yulius Academy
      • Rotterdam, Netherlands
        • Erasmus Medical Centre
      • Coventry, United Kingdom, CV4 7AL
        • Warwick Medical School, University of Warwick
      • London, United Kingdom, SE5 8AF
        • King's College London

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 16 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Young person inclusion:

    1. Provides valid written informed consent, or assent, if below the legal age of consent
    2. If age is within one year of reaching the transition boundary of their CAMHS during the trial recruitment period, and, in exceptional cases, not more than 3 months older than the transition boundary, if a decision about transition has not yet been made
    3. Has a mental disorder defined by DSM-IV-TR, DSM-5 or ICD 10/11, or is under the regular care of CAMHS (if not yet diagnosed)
    4. Has an IQ ≥ 70 as ascertained by previous standardised assessment or diagnosed by clinician, or no indication of intellectual impairment

Exclusion Criteria:

  • 1. Does not provide valid written informed consent, or assent, if below the legal age of consent 2. Is younger than a year before the transition boundary of their CAMHS 3. Has intellectual impairment (IQ <70) as ascertained by previous standardised assessment or diagnosed by clinician (if no data on intellectual functioning are available [because it has never been assessed] then care coordinators will be asked to make a clinical judgement on intellectual impairment before baseline assessment takes place) 4. If not able to (or expected not to be able to) complete the questionnaires due to severe physical disabilities or language problems, even with assistance from family members or research assistant 5. Service user in a secure forensic institution

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TRAM feedback
  1. The completion of the "Transition Readiness and Appropriateness Measure" (TRAM, a standardized structured assessment ) prior to the transition boundary by the child and adolescent mental health service (CAMHS) clinician, young person and parent/carer.
  2. Feedback of TRAM findings to the CAMHS clinician to support decisions made regarding transition, communication with stakeholders and the transition process. Clinicians will be expected to communicate the findings to the young person and parent/carer, and, if a referral is made, to send the TRAM feedback to the adult clinician along with the referral letter.
  3. The clinicians will also receive information prior to recruitment begin on the use of TRAM and the way in which it fits in with optimal transition.
Other Names:
  • Managed transition
No Intervention: Usual care
Patients, parent/carers and clinicians in the control arm will complete the TRAM prior to the transition boundary, but the clinicians won't receive any feedback from it nor any information on the benefits of using the decision support tool.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental health status (need for care) as measured by Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA - clinician version) at 15 months
Time Frame: 15 months
The measure will be completed by a trained MILESTONE research assistant taking into account all available sources of information (including the young person, parent/carer, relevant clinician and the medical records) to ensure accuracy of data.
15 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-rated (i.e. completed by young person) mental health status (need for care) on Health of the Nation Outcome Scale for Children and Adolescents (HONOSCA)
Time Frame: Baseline, 9, 15, and 24 months
Baseline, 9, 15, and 24 months
Transition outcome assessed by the Transition Related Outcome Measure (TROM) questionnaire
Time Frame: Baseline, 9, 15, and 24 months
The TROM is a questionnaire completed by the young person, parent/carer and clinician
Baseline, 9, 15, and 24 months
Emotional and behavioural problems assessed by the Achenbach System of Empirically Based Assessment (ASEBA) Youth Self Report (YSR)/Adult Self Report (ASR) questionnaires (young person)
Time Frame: Baseline, 9, 15, and 24 months
YSR is completed by young people aged 17 years or less; ASR by those 18 years or over
Baseline, 9, 15, and 24 months
Emotional and behavioural problems assessed by the Achenbach System of Empirically Based Assessment (ASEBA) Child Behavior Checklist (CBCL) or Adult Behavior Checklist (ABCL) questionnaires (parent/carer)
Time Frame: Baseline, 9, 15, and 24 months
Parent/carer completes CBCL if young person is 17 years or less; ABCL if young person is 18 years or over
Baseline, 9, 15, and 24 months
Illness severity assessed by Clinical Global Impression Severity (CGIS) scale (CGIseverity)
Time Frame: Baseline, 9, 15, and 24 months
Baseline, 9, 15, and 24 months
Quality of life assessed by World Health Organisation Quality of Life Assessment (WHOQOLBREF)
Time Frame: Baseline, 15, and 24 months
Baseline, 15, and 24 months
Independent behaviour assessed by Independent Behaviour During Consultation Scale (IBDCS)
Time Frame: Baseline, 9, 15, and 24 months, if young person is a current service user
Baseline, 9, 15, and 24 months, if young person is a current service user
Illness perception assessed by the Brief Illness Perception Questionnaire (BIPQ)
Time Frame: Baseline and 24 months
Baseline and 24 months
Barriers to care assessed by Barriers to Care (BtC) checklist
Time Frame: 9, 15, and 24 months, if young person is no longer a service user
9, 15, and 24 months, if young person is no longer a service user
Transition experience and readiness assessed by On Your Own Feet - Transition Experience Scale (OYOF-TES)
Time Frame: at 9, 15 or 24 months, completed only once at the first assessment after transition
at 9, 15 or 24 months, completed only once at the first assessment after transition
Adult functioning assessed by Specific Levels of Functioning Scale (SLOF)
Time Frame: Baseline and 24 months
Baseline and 24 months
Quality Adjusted Life Years (QALYs) assessed by EuroQol generic quality of life questionnaire (EQ-5D-5L)
Time Frame: Baseline, 9, 15, and 24 months
Baseline, 9, 15, and 24 months
Service use assessed by a MILESTONE specific Client Service Receipt Inventory (CSRI)
Time Frame: Baseline, 9, 15, and 24 months
Baseline, 9, 15, and 24 months
Mental health status as measured by Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA - clinician version)
Time Frame: Baseline, 9 months, 24 months
The measure will be completed by a trained MILESTONE research assistant taking into account all available sources of information (including the young person, parent/carer, relevant clinician and the medical records) to ensure accuracy of data.
Baseline, 9 months, 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

January 1, 2017

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

December 28, 2016

First Submitted That Met QC Criteria

January 5, 2017

First Posted (Estimate)

January 6, 2017

Study Record Updates

Last Update Posted (Actual)

November 17, 2017

Last Update Submitted That Met QC Criteria

November 15, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC15/WM/0052
  • ISRCTN83240263 (Registry Identifier: ISRCTN)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Disorder

Clinical Trials on TRAM feedback

3
Subscribe